Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +14 vs. Q2 2024
- Shares held
- 11.7M
- −105.1K (−0.9%) vs. Q2 2024
- Total value
- $25.3M
- −$22.5M (−47.1%) vs. Q2 2024
- New holders
- 23
- 21 more added
- Sold out
- 9
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Novo Holdings A/S | 1,800,000 | $3.91M | 0.19% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,305,239 | $2.83M | 0.03% | −172,510−11.7% | Reduced |
| Farallon Capital Management, L.L.C. | 1,057,201 | $2.29M | 0.01% | −286,000−21.3% | Reduced |
| PFM Health Sciences, LP | 1,034,002 | $2.24M | 0.13% | −233,000−18.4% | Reduced |
| Citadel Advisors LLC | 804,462 | $1.75M | 0.00% | +74,610+10.2% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $1.69M | 0.04% | 00.0% | Unchanged |
| Sozo Ventures GP II, L.P. | 581,577 | $1.26M | 0.65% | 00.0% | Unchanged |
| BlackRock, Inc. | 435,662 | $945.4K | 0.00% | +435,662 | New |
| Millennium Management LLC | 417,878 | $906.8K | 0.00% | +104,716+33.4% | Added |
| Vanguard Group Inc | 373,903 | $811.4K | 0.00% | +157,737+73.0% | Added |
| Norges Bank | 360,202 | $781.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 338,031 | $733.5K | 0.00% | +173,796+105.8% | Added |
| Deep Track Capital, LP | 307,500 | $667.3K | 0.02% | −158,732−34.0% | Reduced |
| ExodusPoint Capital Management, LP | 280,287 | $608.0K | 0.01% | +87,524+45.4% | Added |
| Pura Vida Investments, LLC | 270,618 | $587.2K | 0.97% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 230,305 | $499.8K | 0.00% | +230,305 | New |
| Renaissance Technologies LLC | 182,100 | $395.2K | 0.00% | +182,100 | New |
| Marshall Wace, LLP | 168,639 | $365.9K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 136,624 | $296.5K | 0.00% | +92,468+209.4% | Added |
| Bridgeway Capital Management, LLC | 92,200 | $200.1K | 0.00% | +92,200 | New |
| Two Sigma Investments, LP | 85,606 | $185.8K | 0.00% | +47,912+127.1% | Added |
| Northern Trust Corp | 78,398 | $170.1K | 0.00% | +64,802+476.6% | Added |
| Morgan Stanley | 64,637 | $140.3K | 0.00% | +19,919+44.5% | Added |
| Wells Fargo & Company | 61,606 | $133.7K | 0.00% | +35,294+134.1% | Added |
| Verition Fund Management LLC | 37,675 | $81.8K | 0.00% | +37,675 | New |
| Green Alpha Advisors, LLC | 31,693 | $68.8K | 0.05% | +31,693 | New |
| State Street Corp | 30,744 | $66.7K | 0.00% | +270+0.9% | Added |
| Two Sigma Advisers, LP | 30,300 | $65.8K | 0.00% | +30,300 | New |
| Resolute Partners Group | 26,500 | $57.5K | 0.01% | 00.0% | Unchanged |
| Brown Advisory Inc | 25,006 | $54.3K | 0.00% | +25,006 | New |
| Prudential Financial Inc | 21,800 | $47.3K | 0.00% | +21,800 | New |
| Pathstone Holdings, LLC | 20,648 | $44.8K | 0.00% | +20,648 | New |
| Goldman Sachs Group Inc | 19,629 | $42.6K | 0.00% | +19,629 | New |
| Virtu Financial LLC | 15,263 | $33.0K | 0.00% | +15,263 | New |
| Charles Schwab Investment Management Inc | 14,779 | $32.1K | 0.00% | −30,332−67.2% | Reduced |
| Prelude Capital Management, LLC | 14,074 | $30.5K | 0.00% | +14,074 | New |
| New York State Common Retirement Fund | 13,900 | $30.2K | 0.00% | −12,700−47.7% | Reduced |
| BNP Paribas Arbitrage, SA | 12,799 | $27.8K | 0.00% | +7,256+130.9% | Added |
| Bank of Montreal | 12,441 | $25.4K | 0.00% | +12,441 | New |
| Squarepoint Ops LLC | 11,526 | $25.0K | 0.00% | +1,324+13.0% | Added |
| UBS Group AG | 9,061 | $19.7K | 0.00% | +6,903+319.9% | Added |
| Barclays PLC | 8,698 | $18.9K | 0.00% | +6,532+301.6% | Added |
| JPMorgan Chase & Co | 8,011 | $17.4K | 0.00% | +5,322+197.9% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 7,415 | $16.1K | 0.00% | +7,415 | New |
| Rhumbline Advisers | 5,372 | $11.7K | 0.00% | −1,051−16.4% | Reduced |
| Tower Research Capital LLC (TRC) | 5,247 | $11.4K | 0.00% | +872+19.9% | Added |
| Citigroup Inc | 4,568 | $9.91K | 0.00% | +3,178+228.6% | Added |
| FMR LLC | 4,519 | $9.81K | 0.00% | +4,519 | New |
| US Bancorp | 4,500 | $9.77K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 3,695 | $8.00K | 0.00% | −1,745−32.1% | Reduced |
| Bank of America Corp | 3,622 | $7.86K | 0.00% | +327+9.9% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 3,463 | $7.51K | 0.00% | +3,463 | New |
| Corebridge Financial, Inc. | 3,374 | $7.32K | 0.00% | −21−0.6% | Reduced |
| Cubist Systematic Strategies, LLC | 3,237 | $7.02K | 0.00% | +3,237 | New |
| Advisor Group Holdings, Inc. | 1,469 | $3.19K | 0.00% | +1,469 | New |
| Royal Bank of Canada | 920 | $2.00K | 0.00% | +317+52.6% | Added |
| Principal Securities, Inc. | 687 | $1.49K | 0.00% | +633+1,172.2% | Added |
| Ameritas Investment Partners, Inc. | 618 | $1.34K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 491 | $1.06K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 457 | $992 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 97 | $210 | 0.00% | −2,198−95.8% | Reduced |
| Larson Financial Group LLC | 50 | $109 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 12 | $26 | 0.00% | +12 | New |
| Nisa Investment Advisors, LLC | 8 | $17 | 0.00% | +8 | New |
| Capital Performance Advisors LLP | 5 | $11 | 0.00% | +5 | New |
| Amalgamated Bank | 218 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 88 | $0 | 0.00% | +88 | New |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −583,041−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −245,692−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −99,002−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,244−100.0% | Sold out |
| Bramshill Investments, LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,053−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |